Cargando…
Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19?
During the ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more attention should be paid to the balance of risks and benefits associated with proton pump inhibitors for the following reasons. One of the main functions of gastric juice is to inactivate swallowed micr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417108/ https://www.ncbi.nlm.nih.gov/pubmed/32779119 http://dx.doi.org/10.1007/s40261-020-00963-x |